Enzalutamide

Enzalutamide (formerly MDV3100) is an investigational compound in development for multiple stages of prostate cancer and for breast cancer.

Overview

Medivation and its collaboration partner, Astellas, is developing enzalutamide for multiple stages of prostate cancer and for breast cancer. The Company is conducting several trials of enzalutamide in prostate cancer disease states and in breast cancer.